Research article · 14 Apr 2026
Conference abstractPublished 8 Dec 2016
Medical device reprocessing (MDR) in Alberta medical clinics: Patient safety risk warrants regulatory oversight
College of Physicians and Surgeons of Alberta, Canada
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Historically in Alberta, responsibility for monitoring infection prevention & control (IPAC) in non-governmental, unaccredited medical clinics had fallen on the business owner and/or physicians. In 2007, a sentinel event triggered a government directed review of IPAC in these settings. A program was created under the direction of a 10-member Advisory Committee: Infectious disease specialists, medical officers of health, senior infection control practitioners, and community physicians and surgeons. CPSA has since actively monitored IPAC with a priority on standards for MDR (cleaning, disinfection and sterilization of medical devices). Alberta has approximately 1700 medical facilities in the âÂ?Â?non-governmental, unaccreditedâÂ? category. Over 600 (>35%) perform some type of MDR and these were assessed for adherence to standards during 2008-2015. In 2013, a provincial policy for reporting the most critical deficiencies was formalized. From 2013-15, 131 assessments identified 17 (13.0%) with risks exceeding the reporting threshold to public health. Deficiencies contributing to the likelihood of reporting included but were not limited to inadequate device cleaning, lack of monitoring sterilization cycles for physical (time, temperature), chemical and/or biological parameters, use of unlicensed sterilizers and inadequate level of reprocessing given device risk classification (SpauldingâÂ?Â?s). Post-exposure risk assessment deemed four (3.0%, n=131) a sufficient threat to initiate look backs for blood-borne pathogen exposure (HIV, HBV & HCV). Formal reporting and post-exposure risk assessment confirmed initial observations suggesting clinics performing MDR are at elevated risk of breaching IPAC principles that may jeopardize patient safety. The logistics and value of providing clinic support via robust regulatory controls is worth exploring.
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Infectious Diseases & Therapy.
Research article · 5 May 2025
The Ultimate Cure for the COVID Syndemic
Mini review · 29 Apr 2025
COVID-19 Systematic Mini-Review as of April 2025
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Infectious Diseases & Therapy
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Benjamin Kung”